K02 DA00332/DA/NIDA NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
1999	2
2000	2
2001	3
2002	3
2003	1
2004	1
2005	2
2006	3
2007	4
2008	1
2022	0

1

Buprenorphine: how to use it right.

Johnson RE, Strain EC, Amass L. Johnson RE, et al. Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S59-77. doi: 10.1016/s0376-8716(03)00060-7. Drug Alcohol Depend. 2003. PMID: 12738351 Review.

2

Assessment and treatment of comorbid psychiatric disorders in opioid-dependent patients.

Strain EC. Strain EC. Clin J Pain. 2002 Jul-Aug;18(4 Suppl):S14-27. doi: 10.1097/00002508-200207001-00003. Clin J Pain. 2002. PMID: 12479251 Review.

3

Effects of buprenorphine/naloxone in opioid-dependent humans.

Stoller KB, Bigelow GE, Walsh SL, Strain EC. Stoller KB, et al. Psychopharmacology (Berl). 2001 Mar;154(3):230-42. doi: 10.1007/s002130000637. Psychopharmacology (Berl). 2001. PMID: 11351930 Clinical Trial.

4

Changing profile of abused substances by older persons entering treatment.

Lofwall MR, Schuster A, Strain EC. Lofwall MR, et al. J Nerv Ment Dis. 2008 Dec;196(12):898-905. doi: 10.1097/NMD.0b013e31818ec7ee. J Nerv Ment Dis. 2008. PMID: 19077857 Free PMC article.

5

Effects of buprenorphine versus buprenorphine/naloxone tablets in non-dependent opioid abusers.

Strain EC, Stoller K, Walsh SL, Bigelow GE. Strain EC, et al. Psychopharmacology (Berl). 2000 Mar;148(4):374-83. doi: 10.1007/s002130050066. Psychopharmacology (Berl). 2000. PMID: 10928310 Clinical Trial.

6

Blockade of hydromorphone effects by buprenorphine/naloxone and buprenorphine.

Strain EC, Walsh SL, Bigelow GE. Strain EC, et al. Psychopharmacology (Berl). 2002 Jan;159(2):161-6. doi: 10.1007/s002130100920. Epub 2001 Oct 12. Psychopharmacology (Berl). 2002. PMID: 11862344 Clinical Trial.

7

Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence.

Marsch LA, Stephens MA, Mudric T, Strain EC, Bigelow GE, Johnson RE. Marsch LA, et al. Exp Clin Psychopharmacol. 2005 Nov;13(4):293-302. doi: 10.1037/1064-1297.13.4.293. Exp Clin Psychopharmacol. 2005. PMID: 16366759 Clinical Trial.

8

QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial.

Wedam EF, Bigelow GE, Johnson RE, Nuzzo PA, Haigney MC. Wedam EF, et al. Arch Intern Med. 2007 Dec 10;167(22):2469-75. doi: 10.1001/archinte.167.22.2469. Arch Intern Med. 2007. PMID: 18071169

9

Assessment of agonist and antagonist effects of tramadol in opioid-dependent humans.

Carroll CP, Walsh SL, Bigelow GE, Strain EC, Preston KL. Carroll CP, et al. Exp Clin Psychopharmacol. 2006 May;14(2):109-20. doi: 10.1037/1064-1297.14.2.109. Exp Clin Psychopharmacol. 2006. PMID: 16756415

10

Effects associated with double-blind omission of buprenorphine/naloxone over a 98-h period.

Correia CJ, Walsh SL, Bigelow GE, Strain EC. Correia CJ, et al. Psychopharmacology (Berl). 2006 Dec;189(3):297-306. doi: 10.1007/s00213-006-0571-4. Epub 2006 Sep 30. Psychopharmacology (Berl). 2006. PMID: 17013637 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results